FCA
BMY icon

FinTrust Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

FinTrust Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.1M Buy
21,309
+943
+5% +$44.2K 0.19% 111
2024
Q2 		$846K Sell
20,366
-6,724
-25% -$301K 0.15% 123
2024
Q1 		$1.47M Sell
27,090
-1,102
-4% -$56.1K 0.28% 74
2023
Q4 		$1.45M Sell
28,192
-26,924
-49% -$1.41M 0.29% 74
2023
Q3 		$3.2M Buy
55,116
+2,714
+5% +$166K 0.71% 25
2023
Q2 		$3.77M Hold
52,402
– – 0.9% 20
2023
Q1 		$3.77M Hold
52,402
– – 0.91% 20
2022
Q4 		$3.77M Sell
52,402
-11,637
-18% -$877K 0.91% 20
2022
Q3 		$4.59M Sell
64,039
-296
-0.5% -$21.5K 1.18% 14
2022
Q2 		$4.72M Sell
64,335
-1,240
-2% -$94.4K 1.18% 13
2022
Q1 		$4.79M Buy
65,575
+18,998
+41% +$1.28M 1.1% 14
2021
Q4 		$2.9M Buy
46,577
+30,077
+182% +$1.76M 0.69% 32
2021
Q3 		$976K Sell
16,500
-28,663
-63% -$1.89M 0.26% 81
2021
Q2 		$3.02M Buy
45,163
+1,764
+4% +$115K 0.79% 27
2021
Q1 		$2.74M Buy
43,399
+7,106
+20% +$442K 0.79% 26
2020
Q4 		$2.25M Buy
36,293
+2,867
+9% +$176K 0.72% 32
2020
Q3 		$2.02K Sell
33,426
-1,006
-3% -$60.5K 0.39% 37
2020
Q2 		$2.02M Buy
34,432
+18,741
+119% +$1.12M 0.8% 26
2020
Q1 		$875K Buy
15,691
+1,933
+14% +$118K 0.42% 45
2019
Q4 		$883K Buy
13,758
+8,609
+167% +$493K 0.36% 54
2019
Q3 		$261K Buy
5,149
+2
+0% +$94 0.09% 179
2019
Q2 		$233K Sell
5,147
-91
-2% -$4.24K 0.09% 169
2019
Q1 		$250K Buy
5,238
+655
+14% +$32.6K 0.1% 164
2018
Q4 		$238K Buy
+4,583
New +$246K 0.12% 159

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FinTrust Capital Advisors's BMY Position: Q3 2024 in Review

FinTrust Capital Advisors increased its Bristol-Myers Squibb (BMY) stake by 4.6% in Q3 2024, buying an estimated $44.2K and bringing the position to 21,309 shares worth $1.1M. The position accounts for 0.19% of the portfolio, ranked #111.

FinTrust Capital Advisors first reported a position in BMY in Q4 2018 and has held it in 24 quarters since. The position peaked at $4.79M in Q1 2022. 2,258 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • FinTrust Capital Advisors held 21,309 shares of Bristol-Myers Squibb worth $1.1M as of Q3 2024.
  • FinTrust Capital Advisors bought 943 Bristol-Myers Squibb shares in Q3 2024, an estimated $44.2K.
  • Bristol-Myers Squibb made up 0.19% of FinTrust Capital Advisors's portfolio in Q3 2024, its #111 holding.
  • FinTrust Capital Advisors first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 24 quarters since.
  • FinTrust Capital Advisors's Bristol-Myers Squibb position peaked at $4.79M in Q1 2022.
  • 2,258 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.